GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells
Oncotarget · 2024
DOI: 10.18632/oncotarget.28557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2024. Verfasst von Michael R Booth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Mycosis Fungoides, Skin Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Genzada Pharmaceuticals, Hutchinson, KS 67502, USA.
Zitieren
APA
Booth, M. R., Booth, L., Roberts, J. L., West, C., & Dent, P. (2024). GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget. https://doi.org/10.18632/oncotarget.28557
Vancouver
Booth MR, Booth L, Roberts JL, West C, Dent P. GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget. 2024. doi:10.18632/oncotarget.28557
BibTeX
@article{Booth2024,
author = {Booth, Michael R and Booth, Laurence and Roberts, Jane L and West, Cameron and Dent, Paul},
title = {GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells},
journal = {Oncotarget},
year = {2024},
doi = {10.18632/oncotarget.28557}
}
EUVIMED